Non-viral iPSCs: a safe way for therapy?

References

[1] Ang, Y.S., Tsai, S.Y., Lee, D.F., Monk, J., Su, J., Ratnakumar, K., Ding, J., Ge, Y., Darr, H., Chang, B., . (2011). Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell 145, 183-197 .10.1016/j.cell.2011.03.003
[2] Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., Takada, N., Inoue, M., Hasegawa, M., Kawamata, S., . (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A 108, 14234-14239 .10.1073/pnas.1103509108
[3] Cheng, L., Hansen, N.F., Zhao, L., Du, Y., Zou, C., Donovan, F.X., Chou, B.K., Zhou, G., Li, S., Dowey, S.N., ., and the NISC Comparative Sequencing Program. (2012). Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10, 337-344 .10.1016/j.stem.2012.01.005
[4] Chou, B.-K., Mali, P., Huang, X., Ye, Z., Dowey, S.N., Resar, L.M.S., Zou, C., Zhang, Y.A., Tong, J., and Cheng, L. (2011). Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21, 518-529 .10.1038/cr.2011.12
[5] Efe, J.A., and Ding, S. (2011). The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond B Biol Sci 366, 2208-2221 .10.1098/rstb.2011.0006
[6] Esteban, M.A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., . (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71-79 .10.1016/j.stem.2009.12.001
[7] Feng, B., Ng, J.H., Heng, J.C., and Ng, H.H. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4, 301-312 .10.1016/j.stem.2009.03.005
[8] Gore, A., Li, Z., Fung, H.-L., Young, J.E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M.A., Kiskinis, E., . (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67 .10.1038/nature09805
[9] Hiratsuka, M., Uno, N., Ueda, K., Kurosaki, H., Imaoka, N., Kazuki, K., Ueno, E., Akakura, Y., Katoh, M., Osaki, M., . (2011). Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One 6, e25961.10.1371/journal.pone.0025961
[10] Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E., and Melton, D.A. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26, 795-797 .10.1038/nbt1418
[11] Hussein, S.M., Batada, N.N., Vuoristo, S., Ching, R.W., Autio, R., N?rv?, E., Ng, S., Sourour, M., H?m?l?inen, R., Olsson, C., . (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 .10.1038/nature09871
[12] Jia, F., Wilson, K.D., Sun, N., Gupta, D.M., Huang, M., Li, Z., Panetta, N.J., Chen, Z.Y., Robbins, R.C., Kay, M.A., . (2010). A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7, 197-199 .10.1038/nmeth.1426
[13] Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., and Woltjen, K. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771-775 .10.1038/nature07864
[14] Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K.Y., Lanza, R., . (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476 .10.1016/j.stem.2009.05.005
[15] Laurent, L.C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J.V., Lee, S., Barrero, M.J., . (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 .10.1016/j.stem.2010.12.003
[16] Li, W., and Ding, S. (2010). Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 31, 36-45 .10.1016/j.tips.2009.10.002
[17] Liu, G.H., Barkho, B.Z., Ruiz, S., Diep, D., Qu, J., Yang, S.L., Panopoulos, A.D., Suzuki, K., Kurian, L., Walsh, C., . (2011a). Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225 .10.1038/nature09879
[18] Liu, G.H., Suzuki, K., Qu, J., Sancho-Martinez, I., Yi, F., Li, M., Kumar, S., Nivet, E., Kim, J., Soligalla, R.D., . (2011b). Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688-694 .10.1016/j.stem.2011.04.019
[19] Martins-Taylor, K., Nisler, B.S., Taapken, S.M., Compton, T., Crandall, L., Montgomery, K.D., Lalande, M., and Xu, R.-H. (2011). Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 29, 488-491 .10.1038/nbt.1890
[20] Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A.T., Plath, K., Lowry, W.E., and Benvenisty, N. (2010). Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521-531 .10.1016/j.stem.2010.07.017
[21] Miyoshi, N., Ishii, H., Nagano, H., Haraguchi, N., Dewi, D.L., Kano, Y., Nishikawa, S., Tanemura, M., Mimori, K., Tanaka, F., . (2011). Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8, 633-638 .10.1016/j.stem.2011.05.001
[22] Nguyen, A.T., and Zhang, Y. (2011). The diverse functions of Dot1 and H3K79 methylation. Genes Dev 25, 1345-1358 .10.1101/gad.2057811
[23] Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K., . (2011). A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409-412 .10.1038/nmeth.1591
[24] Onder, T.T., Kara, N., Cherry, A., Sinha, A.U., Zhu, N., Bernt, K.M., Cahan, P., Mancarci, O.B., Unternaehrer, J., Gupta, P.B., . (2012). Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598-602 .10.1038/nature10953
[25] Singhal, N., Graumann, J., Wu, G., Araúzo-Bravo, M.J., Han, D.W., Greber, B., Gentile, L., Mann, M., and Sch?ler, H.R. (2010). Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming. Cell 141, 943-955 .10.1016/j.cell.2010.04.037
[26] Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., . (2009). Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977 .10.1016/j.cell.2009.02.013
[27] Sommer, C.A., Sommer, A.G., Longmire, T.A., Christodoulou, C., Thomas, D.D., Gostissa, M., Alt, F.W., Murphy, G.J., Kotton, D.N., and Mostoslavsky, G. (2010). Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28, 64-74 .
[28] Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S., Kono, T., Shioda, T., and Hochedlinger, K. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175-181 .10.1038/nature09017
[29] Stadtfeld, M., Apostolou, E., Ferrari, F., Choi, J., Walsh, R.M., Chen, T., Ooi, S.S.K., Kim, S.Y., Bestor, T.H., Shioda, T., . (2012). Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet 44, 398-405 .10.1038/ng.1110
[30] Swigut, T., and Wysocka, J. (2007). H3K27 demethylases, at long last. Cell 131, 29-32 .10.1016/j.cell.2007.09.026
[31] Taapken, S.M., Nisler, B.S., Newton, M.A., Sampsell-Barron, T.L., Leonhard, K.A., McIntire, E.M., and Montgomery, K.D. (2011). Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 29, 313-314 .10.1038/nbt.1835
[32] Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 .10.1016/j.cell.2007.11.019
[33] Wang, T., Chen, K., Zeng, X., Yang, J., Wu, Y., Shi, X., Qin, B., Zeng, L., Esteban, M.A., Pan, G., . (2011). The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9, 575-587 .10.1016/j.stem.2011.10.005
[34] Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A., . (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 .10.1016/j.stem.2010.08.012
[35] Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M., H?m?l?inen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., . (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770 .10.1038/nature07863
[36] Wu, S.M., and Hochedlinger, K. (2011). Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 13, 497-505 .10.1038/ncb0511-497
[37] Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., and Thomson, J.A. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801 .10.1126/science.1172482
[38] Yu,J., Vodyanik,M.A., Smuga-Otto,K., Antosiewicz-Bourget,J., Frane,J.L., Tian,S., Nie,J., Jonsdottir,G.A., Ruotti,V., Stewart,R., . (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 .10.1126/science.1151526
[39] Yusa,K., Rad,R., Takeda,J., and Bradley,A. (2009). Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6, 363-369 .10.1038/nmeth.1323
[40] Zhang,W., Ding,Z., and Liu,G.H. (2012). Evolution of iPSC disease models. Protein Cell 3, 1-4 .10.1007/s13238-012-2005-x
[41] Zhang,Z., Jones,A., Sun,C.W., Li, C., Chang, C.W., Joo, H.Y., Dai, Q., Mysliwiec, M.R., Wu, L.C., Guo, Y., . (2011). PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells 29, 229-240 .10.1002/stem.578
[42] Zhao, T., Zhang, Z.-N., Rong, Z., and Xu, Y. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215 .
[43] Zhou, W., and Freed, C.R. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674 .10.1002/stem.201
[44] Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., and Ding, S. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7, 651-655 .10.1016/j.stem.2010.11.015